Centermed Sp. z o.o.

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease1 trial
• Coronary artery disease1 trial
• Heart failure1 trial
• Stroke1 trial
• Type 2 diabetes1 trial

Phase

• Phase 33 trials
• Phase 21 trial

Status

• Completed4 trials

Lead sponsor

• Eli Lilly and Company2 trials
• Amgen1 trial
• Novo Nordisk A/S1 trial

Closed trials

• Completed

  A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin

  NCT06192108· Phase 3· Eli Lilly and Company· Source

• Terminated

  A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)

  NCT05592275· Phase 2· Eli Lilly and Company· Source

• Completed

  ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation

  NCT05021835· Phase 3· Novo Nordisk A/S· Source

• Completed

  Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

  NCT03872401· Phase 3· Amgen· Source